Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 20:17:1156914.
doi: 10.3389/fnins.2023.1156914. eCollection 2023.

Olfactory dysfunction: A plausible source of COVID-19-induced neuropsychiatric symptoms

Alan Pui-Lun Tai  1   2   3 , Mei-Kei Leung  4 , Benson Wui-Man Lau  5 , Shirley Pui-Ching Ngai  5 , Way Kwok-Wai Lau  1   2   3
Affiliations
Review

Olfactory dysfunction: A plausible source of COVID-19-induced neuropsychiatric symptoms

Alan Pui-Lun Tai et al. Front Neurosci. .

Abstract

Olfactory dysfunction and neuropsychiatric symptoms are commonly reported by patients of coronavirus disease 2019 (COVID-19), a respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Evidence from recent research suggests linkages between altered or loss of smell and neuropsychiatric symptoms after infection with the coronavirus. Systemic inflammation and ischemic injury are believed to be the major cause of COVID-19-related CNS manifestation. Yet, some evidence suggest a neurotropic property of SARS-CoV-2. This mini-review article summarizes the neural correlates of olfaction and discusses the potential of trans-neuronal transmission of SARS-CoV-2 or its particles within the olfactory connections in the brain. The impact of the dysfunction in the olfactory network on the neuropsychiatric symptoms associated with COVID-19 will also be discussed.

Keywords: COVID-19; nervus terminalis; neuropsychiatric symptoms; olfactory system; trans-neuronal viral transmission.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
A flowchart illustrating different possible mechanisms that lead to altered functions of the limbic system and the associated neuropsychiatric symptoms in COVID-19.
See this image and copyright information in PMC

References

    1. Altunisik E., Baykan A. H., Sahin S., Aydin E., Erturk S. M. (2021). Quantitative analysis of the olfactory system in COVID-19: An MR imaging study. AJNR Am. J. Neuroradiol. 42 2207–2214. 10.3174/AJNR.A7278 - DOI - PMC - PubMed
    1. Badenoch J. B., Rengasamy E. R., Watson C., Jansen K., Chakraborty S., Sundaram R. D., et al. (2021). Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Commun. 4:fcab297. 10.1093/BRAINCOMMS/FCAB297 - DOI - PMC - PubMed
    1. Baig A. M., Sanders E. C. M. (2020). Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19). J. Med. Virol. 92 1845–1857. 10.1002/jmv.26105 - DOI - PMC - PubMed
    1. Beckman D., Bonillas A., Diniz G. B., Ott S., Roh J. W., Elizaldi S. R., et al. (2022). SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 41:111573. 10.1016/J.CELREP.2022.111573 - DOI - PMC - PubMed
    1. Bilinska K., von Bartheld C. S., Butowt R. (2021). Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19. Front. Cell. Neurosci. 15:247. 10.3389/fncel.2021.674123 - DOI - PMC - PubMed